DRESS typically presents 2 to 8 weeks after exposure to the offending drug. The initial symptoms often include fever and a widespread rash that may resemble measles. The rash can progress to involve large areas of the body and may be accompanied by facial swelling. Patients often experience malaise, fatigue, and swollen lymph nodes. Internal organ involvement is common, with the liver being the most frequently affected organ, leading to hepatitis. Other symptoms may include kidney dysfunction, lung inflammation, and heart complications.

The diagnosis of DRESS is primarily clinical, supported by laboratory findings. A detailed patient history is crucial to identify recent drug exposure. Blood tests typically reveal elevated eosinophil counts and abnormal liver function tests. Additional tests may include a complete blood count, renal function tests, and imaging studies to assess organ involvement. A skin biopsy may be performed to rule out other conditions with similar presentations. It is important to differentiate DRESS from other drug reactions and systemic illnesses.

The cornerstone of DRESS treatment is the immediate discontinuation of the suspected offending drug. Supportive care is essential, including monitoring and managing organ dysfunction. Corticosteroids are often used to reduce inflammation and suppress the immune response. In severe cases, additional immunosuppressive therapies may be required. Treatment is tailored to the individual, depending on the severity of symptoms and the organs involved. Regular follow-up is necessary to monitor recovery and prevent complications.

The prognosis of DRESS varies depending on the severity of the reaction and the promptness of treatment. With early recognition and appropriate management, most patients recover fully, although recovery can be slow, taking weeks to months. However, DRESS can be life-threatening, with a mortality rate of up to 10%. Long-term complications may include persistent organ dysfunction or autoimmune diseases. Recurrence is possible if the patient is re-exposed to the offending drug or similar agents.

DRESS is primarily caused by a hypersensitivity reaction to certain medications. Common culprits include anticonvulsants (such as carbamazepine and phenytoin), antibiotics (such as sulfonamides and vancomycin), and allopurinol, a medication used to treat gout. Genetic factors may predispose individuals to DRESS, with certain genetic markers associated with an increased risk. The exact mechanism of the hypersensitivity reaction is not fully understood but involves complex interactions between the drug, the immune system, and genetic factors.

DRESS is a rare condition, with an estimated incidence of 1 in 1,000 to 1 in 10,000 drug exposures. It affects individuals of all ages but is more common in adults. There is no clear gender predilection. The incidence may vary geographically, influenced by genetic factors and prescribing practices. Due to its rarity and variable presentation, DRESS is often underdiagnosed or misdiagnosed, highlighting the importance of awareness among healthcare providers.

The pathophysiology of DRESS involves a complex immune-mediated reaction. The offending drug or its metabolites may act as haptens, binding to proteins and triggering an immune response. This leads to the activation of T-cells, a type of white blood cell, and the release of cytokines, which cause inflammation and tissue damage. Eosinophils are recruited to the site of inflammation, contributing to the characteristic blood findings. Genetic predispositions, such as specific HLA alleles, may influence susceptibility to DRESS.

Preventing DRESS involves careful prescribing practices and patient education. Healthcare providers should be aware of the drugs commonly associated with DRESS and consider alternative medications when possible, especially in patients with a known genetic predisposition. Patients should be informed about the potential risks and symptoms of DRESS when starting a new medication. Genetic testing may be considered in high-risk populations to identify individuals at increased risk of developing DRESS.

DRESS is a severe drug-induced hypersensitivity reaction characterized by a rash, fever, eosinophilia, and internal organ involvement. Prompt recognition and discontinuation of the offending drug are crucial for effective management. Treatment involves supportive care and, often, corticosteroids. While most patients recover fully, DRESS can be life-threatening and may lead to long-term complications. Awareness of the condition and careful drug prescribing can help prevent its occurrence.

If you or someone you know is taking a new medication and develops symptoms such as a widespread rash, fever, or swelling, it is important to seek medical attention promptly. DRESS is a serious condition that requires immediate medical evaluation. Inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Early diagnosis and treatment are key to a good outcome. Always follow your healthcare provider's instructions regarding medication use and report any unusual symptoms.